AbCellera Biologics Inc. Common Shares
Veridion Score
Composite trend over time
Why is ABCL moving today?
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ABCL.
ABCL insider activity
AbCellera Biologics Inc. Common Shares
2 insiders bought in the last 90 days
Net buying: $1.2M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | 2026-06-03 | Booth Andrew | Insider | buy | $0.19 | 250,000 | 445,600 | $48K | SEC Form 4 |
| 2026-05-18 | 2026-05-14 | Montalbano John S. | Insider | buy | $4.77 | 20,000 | 241,000 | $95K | SEC Form 4 |
| 2026-03-02 | 2026-02-27 | Thermopylae Holdings Ltd. | Insider | buy | $3.44 | 38,000 | 56,134,097 | $131K | SEC Form 4 |
| 2026-02-27 | 2026-02-27 | Booth Andrew | Insider | buy | $3.42 | 42,600 | 195,600 | $146K | SEC Form 4 |
| 2026-02-27 | 2026-02-26 | Thermopylae Holdings Ltd. | Insider | buy | $3.27 | 177,457 | 56,096,097 | $580K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 1 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moABCL contract awards, year to date.
Public federal awards linked to this ticker.
ABCL lobbying filings, year to date.
Registered lobbying filings matched to AbCellera Biologics Inc. Common Shares.